ArticleInvestigational new drugs2022

In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK).

Georgina Meneses-Lorente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.